It is a chemicals private limited company based in Vijayawada, Andhra Pradesh, India, established in 2020.
2020 | Vijayawada, Andhra Pradesh, India | ActiveDelha Pharmaceuticals Private Limited, a active private limited company, was established on 16 March 2020 in Vijayawada, Andhra Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232AP2020PTC114373. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.10 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Jandhyala Naga Lakshmi (Director), Madhu Jandhyala (Director). Past directors included Venkata Pavana Lakshmi Satyavathi Kalakodimi. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D. No. 23-28/2-7A, Challapalli Vari Street, S. N. Puram, Vijayawada, Andhra Pradesh, 520011.
U24232AP2020PTC114373
114373
16 March 2020
₹1.50 M
₹1.10 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Delha Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jandhyala Naga Lakshmi | Director | 16 Mar 2020 | Current |
| Madhu Jandhyala | Director | 07 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Delha Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.35% increase. The company also saw a substantial improvement in profitability, with a 92.92% increase in profit. The company's net worth Soared by an impressive increase of 33.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Delha Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2020 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Delha Pharmaceuticals has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Delha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delha Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Delha Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Delha Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.
The activity A charge with Others of Rs. 2.50 M registered on 08 Jul 2020 with Charge ID 100360232 was modified on 21 Feb 2023. was completed.
The activity Madhu Jandhyala was appointed as a Director was appointed as a Director on 07 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100360232 was registered on 08 Jul 2020. was recorded as a recent event.
Progress on Jandhyala Naga Lakshmi was appointed as a Director was appointed as a Director on 16 Mar 2020 & has been associated with this company since 5 years 9 months . was documented.
The CIN of Delha Pharmaceuticals Private Limited is U24232AP2020PTC114373.
Delha Pharmaceuticals Private Limited is headquartered at D. No. 23-28/2-7A, Challapalli Vari Street, S. N. Puram, Vijayawada, Andhra Pradesh, 520011.
Delha Pharmaceuticals Private Limited was incorporated on 16 March 2020.
The current directors of Delha Pharmaceuticals Private Limited are
The primary industry of Delha Pharmaceuticals Private Limited is Chemicals.
Delha Pharmaceuticals Private Limited is unlisted.
The authorized capital of Delha Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.10 M.
The compliance status of Delha Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX